About

Mighty Capital is an early-growth Silicon Valley venture capital firm. We look for companies with:
  • a strong leadership team,
  • proven product-market fit, and
  • a clear go-to-market strategy.
We are investors in Airbnb, Digital Ocean, Amplitude and MissionBio. Amplitude calls us the “best value for the dollar invested" and says that our network brought them millions of dollars in revenue. The combination of our diverse partnership expertise and our exclusive access to a global business acceleration platform, Products That Count, helps our portfolio drive sales, hire talent, validate ideas, and exit via corporate M&A.
    That is why top-tier venture firms like USVP, Mayfield and Aligned Partners invited us to co-invest with them, and why Business Insider says we’ve come up with “a new way of doing venture capital.”
      If you or someone you know runs a company that meets those criteria, we’d love to hear about it! The best way to get in touch with us is via a mutual connection, most likely a current investor or your law firm. If that’s not an option, then email dealflow@mighty.capital.

      Blog


      September 4, 2017

      A killer pitch deck sounds like a story by design. It is meant to help you step back from the details of your business or new product, to tell a compelling story to an investor. It reads as simple as this: “We are a unique team, excited to solve a big and hard problem. We came up with a sustainably differentiated solution. As a result, we are gaining solid traction, which we monetize fairly. So our financials look extremely promising but to get there, we need a reasonable amount of funding. We have a credible plan to generate significant returns for our investors.”

      Read More

      February 3, 2017

      When a due diligence is appropriate, we ask the entrepreneur to make a data room available to the due diligence team. Through a review of the material in the data room and discussions with the CEO, exec team and references, the due diligence lead is able to cover the key aspects of the due diligence: team, business, financing, and match with Mighty Capital.

      Read More

      November 12, 2019

      We had a lot of fun at our holiday party and are grateful to the investors, entrepreneurs and friends who were able to join us. This post includes a brief video capturing the vibe of the event.

      Read More

      August 2, 2019

      SC Moatti was honored to recently be interviewed by Innovation Hong Kong. Read about her experience, her thoughts on AI, and a few updates on Mighty Capital and Products That Count.

      Read More

      July 12, 2019

      Deal brings single-cell genomics to China and accelerates Mission Bio’s mission to predict and prevent cancer relapse on a global scale

      Read More

      June 27, 2019

      An effective branding strategy requires seeing your entire constituent universe and transmitting a constant, cohesive and comprehensive values message.

      Read More

      May 21, 2019

      Cancer is smart. Yes, you read that right.

      The disease isn’t intelligent in the traditional sense — but cancer cells are adaptable, ‘learning’ from their environment and constantly evolving to improve survival. While targeted therapy can be effective at first, this evolution means that treatment resistance and disease progression remain a challenge.

      To effectively combat cancer — to both detect it sooner and develop the most impactful, dynamic therapies — we need to be able to understand it. This means tracking the progression of each and every cancerous cell.

      Read More

      May 7, 2019

      How top marketers are winning against digital-only disruptors by bringing location to the cloud.

      Read More

      May 3, 2019

      Listen to the Product Guru Bruce Cleveland discuss the importance of Bridging The Traction Gap for startups and investors alike:

      • Building the framework for success factors that turn startups into sustainable businesses
      • What it takes for companies with promising tech to become industry powerhouses
      • The difference between seeking out investors and having investors come to you
      Read More

      April 24, 2019

      Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) and its partners, including Fabric Genomics, have today published in Science Translational Medicine a new study documenting the process to diagnose rare genetic diseases in record time. This new method speeds answers to physicians and allows increased use of genome sequencing as a first-line diagnostic test for critically ill babies.

      Read More

      April 12, 2019

      Mighty Capital, whose founder and managing partner is SC Moatti, has its first liquidity event. SC tells Women’s PE Briefs that the firm sold a small portion of its first investment, Amplitude.

      Read More

      April 12, 2019

      Hear from the leader as one of Mighty Capital’s portfolio companies share his experience delivering customer delight through product:

      • The power of authentic customer delight
      • Driving efficiencies for growth with a personal touch
      • Staying true to your company’s mission and core values

      To effectively scale a business, it’s critical to focus on providing customer delight with marketing tactics that are rooted in the product’s core value.

      Read More

      © 2019 Mighty Capital All Rights Reserved